Results 61 to 70 of about 4,554 (207)

Abscopal Effect in Radiation Therapy: The Immune Mechanisms and Clinical Advances

open access: yesMedComm, Volume 7, Issue 9, September 2026.
The schematic outlines the key events of the abscopal effect. (Ignition) Local radiotherapy (RT) induces the release of immunogenic signals from the tumor, leading to dendritic cell (DC) activation. (Orchestration) In the tumor‐draining lymph node (TDLN), DCs prime naive T cells into cytotoxic T lymphocytes (CTLs), a process modulated by regulatory T ...
Yihong Dong   +5 more
wiley   +1 more source

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer

open access: yesFrontiers in Oncology, 2019
Metastatic non-small cell lung cancer (NSCLC) is associated with a limited survival when treated with palliative intent platinum-based chemotherapy alone.
Caryn Wujanto   +9 more
doaj   +1 more source

Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy?

open access: yes, 2019
To evaluate safety and efficacy of image guided-hypofractionated radiation therapy (IG-HRT) in patients with thoracic nodes ...
Scorsetti M.   +13 more
core   +1 more source

Clinical studies of chemotherapy efficacy in combination with androgenic deprivation in patients with oligometastatic hormone-sensitive prostate cancer

open access: yesМедицинский совет, 2019
Prostate cancer is one of the most common malignant neoplasms in men. Nowadays, the overall mortality rate of this disease continues to increase, including due to the high frequency of primary detection of its widespread and metastatic forms.
S. V. Popov
doaj   +1 more source

Real‐world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study

open access: yesInternational Journal of Cancer, Volume 159, Issue 3, Page 683-698, 1 August 2026.
What's New? Although patients with melanoma brain metastases (MBM) may benefit from treatment with immune checkpoint inhibitors (ICIs), which are known to improve survival in advanced melanoma, MBM patients have often been excluded from trials evaluating ICIs.
Ralf Gutzmer   +18 more
wiley   +1 more source

Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects [PDF]

open access: yes, 2016
Background: To investigate the prognostic value of oligo-recurrence in patients with brain-only oligometastases of non-small cell lung cancer (NSCLC) treated with stereotactic radiosurgery (SRS) or stereotactic radiotherapy (SRT).
Keiichi Jingu   +13 more
core   +1 more source

Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis

open access: yesFrontiers in Oncology, 2023
PurposeThis study is aimed to explore risk factors affect the therapy outcomes of adrenal metastases (AM) for stereotactic body radiation therapy (SBRT) and guide clinical dose selection.Methods and materialsPubMed, Embase and Web of Science were ...
Xuehong Liao   +9 more
doaj   +1 more source

Oligoprogressive renal cell carcinoma: What is the role of surgery?

open access: yesBJU International, Volume 138, Issue 2, Page 219-228, August 2026.
Objective To provide an overview of the biological mechanism and pattern of oligoprogression in renal cell carcinoma (RCC) and the most updated role of surgery in this setting, highlighting scientific gaps and informing future implications. Methods A non‐systematic search of PubMed/MEDLINE was performed in August 2025 including guidelines, reviews, and
Chiara Re   +9 more
wiley   +1 more source

Oligometastases/Oligo-Recurrence of Lung Cancer [PDF]

open access: yesPulmonary Medicine, 2013
Metastasis or recurrence of cancer has been considered as representing a near terminal life stage. As a result, for a long time, cancer patients with metastasis or recurrence have been classified as one group and treated using only systemic therapy. However, recent advances in cancer therapy have dramatically improved both local and systemic therapies.
Yuzuru Niibe   +5 more
openaire   +3 more sources

Expert Consensus on the Combined Application of Radiotherapy and Novel Systemic Agents in Breast Cancer Treatment

open access: yesJournal of Evidence-Based Medicine, Volume 19, Issue 2, June 2026.
ABSTRACT The rapid advancement of radiotherapy techniques and systemic anticancer agents has created unprecedented opportunities to improve outcomes for breast cancer patients, while also introducing new challenges related to optimal integration and safety.
Jie Lan   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy